Low-level toxicant perturbation of neural cell function

神经细胞功能的低水平毒物扰动

基本信息

  • 批准号:
    7050328
  • 负责人:
  • 金额:
    $ 37.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-02-01 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This research is focused on understanding how non-catastrophic toxicant exposure disrupts normal development and function of the CNS. The continuing determination that concentrations of toxicants once thought to be safe are associated with a variety of maladies, combined with the large numbers of toxicants and potential toxicants found in our environment, make it of great importance to increase our understanding of how normal cellular function may be disrupted by such substances. A central goal of this effort is to identify general principles applicable to the understanding of large numbers of toxicants. The general principle/hypothesis that underlies this application, which emerges directly from our ongoing research, is that, regardless of its other activities, any toxicant that has pro-oxidant activity will have a highly predictable set of effects on both precursor cells and differentiated cells. These effects include inhibition of precursor cell division and enhancement of responsiveness to inducers of differentiation and cell death. This hypothesis, with its clear mechanistic predictions, allows the formulation of a general theory of developmental neurotoxicology applicable to exposure to a wide range of toxicants at concentrations that frequently occur in the environment. Moreover, the predictions of our hypothesis regarding the effects of low dose toxicant exposure on vulnerability to other potentially harmful agents may provide a new understanding of the reasons underlying the enormous variability seen in responsiveness of different individuals to putatively identical physiological stressors. Our in preliminary vitro experimentation provides strong support for the correctness of the hypothesis underlying this proposal, and has demonstrated marked effects of a variety of toxicants on neural cell function, including a striking enhancement of vulnerability to a variety of other physiological stressors. Biochemical analysis demonstrates that despite their different chemistries, all of the toxicants examined converge on Fyn and Cbl activation, leading to enhanced degradation of the PDGFRa. In sum, this research program will define the actions of sublethal concentrations of single toxicants on a variety of neural precursor cells, define the interactions of toxicants with other physiological stressors (including other toxicants) particularly in regards to synergistic toxicity reactions, will define cellular regulatory systems that are modulated by toxicant exposure, and will study clinically relevant situations in which toxicant load can enhance response to injury and in which follow on studies in human populations are both particularly important and comparatively straightforward to carry out.
描述(由申请人提供):本研究的重点是了解非灾难性毒物暴露如何破坏CNS的正常发育和功能。人们不断地确定,曾经被认为是安全的有毒物质的浓度与各种疾病有关,再加上在我们的环境中发现了大量的有毒物质和潜在的有毒物质,因此,增加我们对这些物质如何破坏正常细胞功能的理解非常重要。这项工作的一个中心目标是确定适用于理解大量有毒物质的一般原则。作为本申请的基础的一般原理/假设直接来自我们正在进行的研究,其是,无论其其他活性如何,具有促氧化活性的任何毒物都将对前体细胞和分化细胞具有高度可预测的一组影响。这些作用包括抑制前体细胞分裂和增强对分化和细胞死亡诱导剂的反应性。这一假说,其明确的机制预测,允许制定一个一般的理论适用于暴露于广泛的有毒物质的浓度,经常发生在环境中的发育神经毒理学。此外,我们的假设的预测低剂量毒物暴露对其他潜在的有害物质的脆弱性的影响可能提供一个新的理解的原因的巨大的变化,看到不同的个人puerestival相同的生理应激反应。我们的初步体外实验为这一假设的正确性提供了强有力的支持,并证明了各种毒物对神经细胞功能的显着影响,包括对各种其他生理应激源的脆弱性的显着增强。生物化学分析表明,尽管它们的化学性质不同,但所有检查的毒物都集中在Fyn和Cbl活化上,导致PDGFRa的降解增强。总之,本研究计划将确定亚致死浓度的单一毒物对各种神经前体细胞的作用,确定毒物与其他生理应激源的相互作用,(包括其他毒物),特别是在协同毒性反应方面,将定义受毒物暴露调节的细胞调节系统,并将研究临床相关情况,其中毒物负荷可以增强对损伤的反应,以及在人群中进行的后续研究特别重要且相对简单。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK D NOBLE其他文献

MARK D NOBLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK D NOBLE', 18)}}的其他基金

Mechanism-based drug repurposing and novel treatments for glioblastoma
基于机制的药物再利用和胶质母细胞瘤的新疗法
  • 批准号:
    9891963
  • 财政年份:
    2017
  • 资助金额:
    $ 37.05万
  • 项目类别:
Mechanism-based drug repurposing and novel treatments for glioblastoma
基于机制的药物再利用和胶质母细胞瘤的新疗法
  • 批准号:
    9453659
  • 财政年份:
    2017
  • 资助金额:
    $ 37.05万
  • 项目类别:
CNS vulnerability to systemic chemotherapy: Causes and prevention
中枢神经系统对全身化疗的脆弱性:原因和预防
  • 批准号:
    7533303
  • 财政年份:
    2008
  • 资助金额:
    $ 37.05万
  • 项目类别:
CNS vulnerability to systemic chemotherapy: Causes and prevention
中枢神经系统对全身化疗的脆弱性:原因和预防
  • 批准号:
    7666255
  • 财政年份:
    2008
  • 资助金额:
    $ 37.05万
  • 项目类别:
White matter damage in Alzheimer?s disease: New cellular targets and mechanisms
阿尔茨海默病中的白质损伤:新的细胞靶点和机制
  • 批准号:
    7471948
  • 财政年份:
    2008
  • 资助金额:
    $ 37.05万
  • 项目类别:
White matter damage in Alzheimer?s disease: New cellular targets and mechanisms
阿尔茨海默病中的白质损伤:新的细胞靶点和机制
  • 批准号:
    7577523
  • 财政年份:
    2008
  • 资助金额:
    $ 37.05万
  • 项目类别:
CNS vulnerability to systemic chemotherapy: Causes and prevention
中枢神经系统对全身化疗的脆弱性:原因和预防
  • 批准号:
    8270549
  • 财政年份:
    2008
  • 资助金额:
    $ 37.05万
  • 项目类别:
CNS vulnerability to systemic chemotherapy: Causes and prevention
中枢神经系统对全身化疗的脆弱性:原因和预防
  • 批准号:
    8076398
  • 财政年份:
    2008
  • 资助金额:
    $ 37.05万
  • 项目类别:
CNS vulnerability to systemic chemotherapy: Causes and prevention
中枢神经系统对全身化疗的脆弱性:原因和预防
  • 批准号:
    7878840
  • 财政年份:
    2008
  • 资助金额:
    $ 37.05万
  • 项目类别:
Low-level toxicant perturbation of neural cell function
神经细胞功能的低水平毒物扰动
  • 批准号:
    7171812
  • 财政年份:
    2006
  • 资助金额:
    $ 37.05万
  • 项目类别:

相似海外基金

Self-Assembling Camptothecin Nanofiber Hydrogels as Adjunct Therapy for Intraoperative Treatment of Malignant Glioma
自组装喜树碱纳米纤维水凝胶作为恶性胶质瘤术中治疗的辅助疗法
  • 批准号:
    10738545
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure
使用多模块 HDAd 载体进行体内 HSC 基因治疗以治愈 HIV
  • 批准号:
    10599503
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
抗CD25放射免疫治疗和全骨髓照射治疗复发难治性急性白血病
  • 批准号:
    10435886
  • 财政年份:
    2022
  • 资助金额:
    $ 37.05万
  • 项目类别:
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
抗CD25放射免疫治疗和全骨髓照射治疗复发难治性急性白血病
  • 批准号:
    10576955
  • 财政年份:
    2022
  • 资助金额:
    $ 37.05万
  • 项目类别:
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
  • 批准号:
    10374792
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Novel DNA damage response inhibitor and alkylator combinations for GBM
用于 GBM 的新型 DNA 损伤反应抑制剂和烷化剂组合
  • 批准号:
    10305365
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Novel DNA damage response inhibitor and alkylator combinations for GBM
用于 GBM 的新型 DNA 损伤反应抑制剂和烷化剂组合
  • 批准号:
    10492774
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Novel DNA damage response inhibitor and alkylator combinations for GBM
用于 GBM 的新型 DNA 损伤反应抑制剂和烷化剂组合
  • 批准号:
    10704630
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Tunable Temporal Drug Release for Optimized Synergistic Combination Therapy of Glioblastoma
可调节的时间药物释放,用于优化胶质母细胞瘤的协同联合治疗
  • 批准号:
    10449370
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
  • 批准号:
    10570900
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了